FDA advisors vote against effectiveness of Biogen’s ALS drug
A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesThe Food and Drug Administration's independent panel of advisors on Wednesday voted against…